Sex differences in adherence to guidelines in aspirin prescription in a population of low-risk cardiovascular patients

Abstract

Get full access to this article

View all access options for this article.

References

Eindhoven

Hilt

Zwaan

et al.

Age and gender differences in medical adherence after myocardial infarction: Women do not receive optimal treatment - The Netherlands claims database. Eur J Prev Cardiol 2018; 25: 181–189.

Mattioli

Bonetti

Zennaro

et al.

Acute myocardial infarction in young patients: Nutritional status and biochemical factors. Int J Cardiol 2005; 101: 185–190.

Rodríguez

Cea-Soriano

Martín-Merino

et al.

Discontinuation of low dose aspirin and risk of myocardial infarction: Case-control study in UK primary care. BMJ 2011; 343: d4094–d4094.

Burger

Chemnitius

Kneissl

et al.

Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation: Review and meta-analysis. J Intern Med 2005; 257: 399–414.

Vinther

Jacobsen

Jørgensen

. Current European guidelines for management of cardiovascular disease: Is medical treatment in nearly half a population realistic? Eur J Prev Cardiol 2018; 25: 157–163.

Xing M, Shi Y, Zhu X, et al. How aspirin prevents cardiovascular diseases. Eur J Prev Cardiol. 2018; 25: 640.

Sundström

Hedberg

Thuresson

et al.

Low-dose aspirin discontinuation and risk of cardiovascular events: A Swedish nationwide, population-based cohort study. Circulation 2017; 136: 1183–1192.

Manteuffel

Williams

Chen

et al.

Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. J Womens Health (Larchmt) 2014; 23: 112–119.